Financial Statements, Business Model, and Company Analysis

Learn how Series 86 tests statement analysis, company fundamentals, business quality, management execution, and the drivers of profit and growth.

Series 86 expects the analyst to treat financial statements as evidence, not as decoration around the narrative. Income statements, balance sheets, cash flow statements, 10-Ks, 10-Qs, and company disclosures are where the business model becomes testable. The exam therefore rewards answers that connect the numbers to the business rather than quoting the numbers without interpretation.

The outline points to revenue, costs, working capital, capital structure, customer concentration, inventory turnover, receivable turnover, payables turnover, capacity for growth, capital expenditures, and management quality because all of those help explain whether the company’s growth and profitability are durable. A company may report strong earnings while stretching receivables, underinvesting in capacity, or depending too heavily on one customer. Those details matter because they change the research conclusion.

What a strong analyst is checking

AreaKey questionWhy it matters
revenue qualitywhere does growth come from?tests whether growth is repeatable or low quality
cost structurewhat drives margins?shows operating leverage and downside risk
working capitalhow much cash is tied up?affects liquidity and cash-flow strength
capital structurehow is the business financed?affects flexibility, risk, and valuation
customer concentrationhow dependent is the company on a few relationships?exposes fragility hidden by headline growth
management executioncan the plan be implemented realistically?distinguishes a story from an investable thesis

Business-model analysis goes beyond financial ratios

The outline includes legal structure, supply chain, contract structure, product assessment, and business plan implementation because the candidate is expected to judge how the company actually makes money. Two firms with similar current margins can deserve very different research views if one depends on a fragile contract base and the other has recurring demand with strong switching costs.

That is why the exam often rewards answers that combine qualitative and quantitative evidence. A metric may look attractive, but if it depends on an unstable supplier relationship or a product strategy that is losing relevance, the stronger answer will reflect that weakness.

Company analysis should connect statements to strategy

A good Series 86 response usually links the statements to the strategic question. If management is promising growth, the analyst should check whether capacity, capex, working capital, and customer demand support that promise. If margins are improving, the analyst should ask whether pricing, mix, volume, or one-time items are driving the change. If the business is taking on more debt, the analyst should evaluate whether the capital structure still fits the cash-flow profile.

The exam point is not just ratio literacy. It is analytical coherence.

Key Takeaways

  • Series 86 treats financial statements as evidence about business quality, not just about historical results.
  • Strong company analysis combines accounting data, business-model logic, and management execution.
  • The best answer usually explains why the numbers support or weaken the strategic story.

Sample Exam Question

A company reports strong earnings growth, but receivables are rising much faster than revenue and customer concentration is increasing. What is the strongest Series 86 reaction?

A. Treat the earnings growth as fully confirmed because net income is positive
B. Ignore receivables because balance-sheet items do not matter to equity research
C. Investigate whether revenue quality and collection risk weaken the apparent strength of the results
D. Upgrade the stock immediately because sales growth overrides all other concerns

Answer: C. Series 86 expects the analyst to question whether reported growth is high quality and sustainable, especially when working-capital metrics and concentration risk deteriorate.

Revised on Thursday, April 23, 2026